Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Rational design of peptides for identification of linear epitopes and generation of neutralizing monoclonal antibodies against DKK2 for cancer therapy

Rational design of peptides for identification of linear epitopes and generation of neutralizing... Dickkopf-related protein 2 (DKK2)is a member of the Dickkopf family in Wnt signaling pathway. Recently, we found that antibodies against DKK2 could activate natural killer (NK) and CD8+ T cells in tumors and inhibit tumor growth. In this paper, we report the rational design of peptides for identification of linear epitopes and generation of neutralizing monoclonal anti-DKK2 antibodies. To break the immune tolerance, we designed and chemically synthesized six peptides corresponding to different regions of DKK2 as immunogens and found five of them could generate mouse polyclonal antibodies that can bind to the active recombinant human DKK2 protein. Neutralizing mouse monoclonal antibodies (5F8 and 1A10) against human DKK2 were successfully developed by immunizing the mice with two different peptides (34KLNSIKSSL42 and 240KVWKDATYS248) conjugated to Keyhole limpet hemocyanin (KLH). The monoclonal antibodies not only abolish DKK2’s suppression of Wnt signaling in vitro but also inhibits tumor growth in vivo. Currently, those two mAbs are undergoing humanization as immunotherapy candidates and may offer a new drug for treatment of human cancers. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Antibody Therapeutics Oxford University Press

Rational design of peptides for identification of linear epitopes and generation of neutralizing monoclonal antibodies against DKK2 for cancer therapy

Download PDF
8 pages

Loading next page...
 
/lp/oxford-university-press/rational-design-of-peptides-for-identification-of-linear-epitopes-and-8pNSyl7m6O
Publisher
Oxford University Press
Copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of Antibody Therapeutics.
eISSN
2516-4236
DOI
10.1093/abt/tbaa004
Publisher site
See Article on Publisher Site

Abstract

Dickkopf-related protein 2 (DKK2)is a member of the Dickkopf family in Wnt signaling pathway. Recently, we found that antibodies against DKK2 could activate natural killer (NK) and CD8+ T cells in tumors and inhibit tumor growth. In this paper, we report the rational design of peptides for identification of linear epitopes and generation of neutralizing monoclonal anti-DKK2 antibodies. To break the immune tolerance, we designed and chemically synthesized six peptides corresponding to different regions of DKK2 as immunogens and found five of them could generate mouse polyclonal antibodies that can bind to the active recombinant human DKK2 protein. Neutralizing mouse monoclonal antibodies (5F8 and 1A10) against human DKK2 were successfully developed by immunizing the mice with two different peptides (34KLNSIKSSL42 and 240KVWKDATYS248) conjugated to Keyhole limpet hemocyanin (KLH). The monoclonal antibodies not only abolish DKK2’s suppression of Wnt signaling in vitro but also inhibits tumor growth in vivo. Currently, those two mAbs are undergoing humanization as immunotherapy candidates and may offer a new drug for treatment of human cancers.

Journal

Antibody Therapeutics – Oxford University Press

Published: Apr 13, 2020

Keywords: DKK2; rational peptide design; neutralizing epitope; monoclonal antibody; immunotherapy

References

  • Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer
    Chung, KY; Gore, I; Fong, L
  • Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
    Brahmer, JR; Tykodi, SS; Chow, LQ
  • Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
    Topalian, SL; Hodi, FS; Brahmer, JR
  • Oncology meets immunology: the cancer-immunity cycle
    Chen, DS; Mellman, I
  • The blockade of immune checkpoints in cancer immunotherapy
    Pardoll, DM
  • Immune checkpoint blockade: a common denominator approach to cancer therapy
    Topalian, SL; Drake, CG; Pardoll, DM
  • Primary, adaptive, and acquired resistance to cancer immunotherapy
    Sharma, P; Hu-Lieskovan, S; Wargo, JA
  • Comprehensive molecular characterization of human colon and rectal cancer
    Cancer Genome Atlas, N
  • Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma
    Hugo, W; Zaretsky, JM; Sun, L
  • Loss of PTEN promotes resistance to T cell-mediated immunotherapy
    Peng, W; Chen, JQ; Liu, C
  • sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
    Kaur, A; Webster, MR; Marchbank, K
  • Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene
    Su, LK; Kinzler, KW; Vogelstein, B
  • The complex world of WNT receptor signalling
    Niehrs, C
  • Function and biological roles of the Dickkopf family of Wnt modulators
    Niehrs, C
  • The structural basis of DKK-mediated inhibition of Wnt/LRP signaling. Sci Signal, 5, pe22
    Bao, J; Zheng, JJ; Wu, D
  • The canonical Wnt signaling antagonist DKK2 is an essential effector of PITX2 function during normal eye development
    Gage, PJ; Qian, M; Wu, D
  • Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation
    Li, X; Liu, P; Liu, W
  • Dkk2 plays an essential role in the corneal fate of the ocular surface epithelium
    Mukhopadhyay, M; Gorivodsky, M; Shtrom, S
  • Chemical and genetic evidence for the involvement of Wnt antagonist Dickkopf2 in regulation of glucose metabolism
    Li, X; Shan, J; Chang, W
  • Second cysteine-rich domain of Dickkopf-2 activates canonical Wnt signaling pathway via LRP-6 independently of dishevelled
    Li, L; Mao, J; Sun, L
  • DKK2 imparts tumor immunity evasion through beta-catenin-independent suppression of cytotoxic immune-cell activation
    Xiao, Q; Wu, J; Wang, WJ
  • Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides
    Li, X; Mao, C; Ma, S
  • Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides
    Foo, DGW; Alonso, S; Meng, CP
  • A PLCβ/PI3Kγ-GSK3 signaling pathway regulates Cofilin phosphatase Slingshot2 and neutrophil polarization and Chemotaxis
    Tang, W; Zhang, Y; Xu, W
  • The CHMP4b- and Src-docking sites in the Bro1 domain are autoinhibited in the native state of Alix
    Xi, Z; Shujuan, P; Le, S
  • Integrin-induced PIP5K1C kinase polarization regulates neutrophil polarization, directionality, and in vivo infiltration
    Xu, W; Wang, PB; Zhang, Y